252 related articles for article (PubMed ID: 26498018)
1. Extracardiac-Lodged Mesenchymal Stromal Cells Propel an Inflammatory Response Against Myocardial Infarction via Paracrine Effects.
Peng Y; Pan W; Ou Y; Xu W; Kaelber S; Borlongan CV; Sun M; Yu G
Cell Transplant; 2016; 25(5):929-35. PubMed ID: 26498018
[TBL] [Abstract][Full Text] [Related]
2. In Situ Preconditioning of Human Mesenchymal Stem Cells Elicits Comprehensive Cardiac Repair Following Myocardial Infarction.
Sim WS; Park BW; Ban K; Park HJ
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535594
[TBL] [Abstract][Full Text] [Related]
3. Epicardial placement of human MSC-loaded fibrin sealant films for heart failure: Preclinical efficacy and mechanistic data.
Fields L; Ito T; Kobayashi K; Ichihara Y; Podaru MN; Hussain M; Yamashita K; Machado V; Lewis-McDougall F; Suzuki K
Mol Ther; 2021 Aug; 29(8):2554-2570. PubMed ID: 33887461
[TBL] [Abstract][Full Text] [Related]
4. The beneficial effects of mesenchymal stem cells and their exosomes on myocardial infarction and critical considerations for enhancing their efficacy.
Ala M
Ageing Res Rev; 2023 Aug; 89():101980. PubMed ID: 37302757
[TBL] [Abstract][Full Text] [Related]
5. The Role of Mesenchymal Stem/Stromal Cells Secretome in Macrophage Polarization: Perspectives on Treating Inflammatory Diseases.
Ti D; Yi J; Chen H; Hao H; Shi C
Curr Stem Cell Res Ther; 2024; 19(6):894-905. PubMed ID: 37723965
[TBL] [Abstract][Full Text] [Related]
6. Research Progress on Cardiac Tissue Construction of Mesenchymal Stem Cells for Myocardial Infarction.
Yang GD; Ma DS; Ma CY; Bai Y
Curr Stem Cell Res Ther; 2024; 19(7):942-958. PubMed ID: 37612870
[TBL] [Abstract][Full Text] [Related]
7. Administration of cardiac mesenchymal cells modulates innate immunity in the acute phase of myocardial infarction in mice.
Kang Y; Nasr M; Guo Y; Uchida S; Weirick T; Li H; Kim J; Moore JB; Muthusamy S; Bolli R; Wysoczynski M
Sci Rep; 2020 Sep; 10(1):14754. PubMed ID: 32901075
[TBL] [Abstract][Full Text] [Related]
8. Human Bone Marrow Mesenchymal Stem Cells Promote the M2 Phenotype in Macrophages Derived from STEMI Patients.
Cortés-Morales VA; Vázquez-González WG; Montesinos JJ; Moreno-Ruíz L; Salgado-Pastor S; Salinas-Arreola PM; Díaz-Duarte K; Chávez-Rueda AK; Chávez-Sánchez L
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003447
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells influence monocyte/macrophage phenotype: Regulatory mode and potential clinical applications.
Lu D; Jiao X; Jiang W; Yang L; Gong Q; Wang X; Wei M; Gong S
Biomed Pharmacother; 2023 Sep; 165():115042. PubMed ID: 37379639
[TBL] [Abstract][Full Text] [Related]
10. Potency assay to predict the anti-inflammatory capacity of a cell therapy product for macrophage-driven diseases: overcoming the challenges of assay development and validation.
Sadeghi S; Nimtz L; Niebergall-Roth E; Norrick A; Hägele S; Vollmer L; Esterlechner J; Frank MH; Ganss C; Scharffetter-Kochanek K; Kluth MA
Cytotherapy; 2024 May; 26(5):512-523. PubMed ID: 38441512
[TBL] [Abstract][Full Text] [Related]
11. Local delivery of stem cell spheroids with protein/polyphenol self-assembling armor to improve myocardial infarction treatment via immunoprotection and immunoregulation.
An C; Shao F; Long C; Zhang Y; Nie W; Zeng R; Dou Z; Zhao Y; Lin Y; Zhang S; Zhang L; Ren C; Zhang Y; Zhou G; Wang H; Liu J
Biomaterials; 2024 Jun; 307():122526. PubMed ID: 38513434
[TBL] [Abstract][Full Text] [Related]
12. Research and application of hydrogel-encapsulated mesenchymal stem cells in the treatment of myocardial infarction.
Guan H; Chen Y; Liu X; Huang L
Colloids Surf B Biointerfaces; 2024 Jul; 239():113942. PubMed ID: 38729022
[TBL] [Abstract][Full Text] [Related]
13. Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke.
Eckert MA; Vu Q; Xie K; Yu J; Liao W; Cramer SC; Zhao W
J Cereb Blood Flow Metab; 2013 Sep; 33(9):1322-34. PubMed ID: 23756689
[TBL] [Abstract][Full Text] [Related]
14. MiR-101a loaded extracellular nanovesicles as bioactive carriers for cardiac repair.
Wang J; Lee CJ; Deci MB; Jasiewicz N; Verma A; Canty JM; Nguyen J
Nanomedicine; 2020 Jul; 27():102201. PubMed ID: 32278100
[TBL] [Abstract][Full Text] [Related]
15. A Self-Homing and Traceable Cardiac Patch Leveraging Ferumoxytol for Spatiotemporal Therapeutic Delivery.
Li M; Liu Y; Huang B; Zhou G; Pan M; Jin J; Wang F; Wang Y; Ren X; Xu B; Hu B; Gu N
ACS Nano; 2024 Jan; 18(4):3073-3086. PubMed ID: 38227475
[TBL] [Abstract][Full Text] [Related]
16. Use of adult mesenchymal stromal cells in tissue repair: impact of physical exercise.
Bourzac C; Bensidhoum M; Pallu S; Portier H
Am J Physiol Cell Physiol; 2019 Oct; 317(4):C642-C654. PubMed ID: 31241985
[TBL] [Abstract][Full Text] [Related]
17. Failure to launch commercially-approved mesenchymal stromal cell therapies: what's the path forward? Proceedings of the International Society for Cell & Gene Therapy (ISCT) Annual Meeting Roundtable held in May 2023, Palais des Congrès de Paris, Organized by the ISCT MSC Scientific Committee.
Robb KP; Galipeau J; Shi Y; Schuster M; Martin I; Viswanathan S
Cytotherapy; 2024 May; 26(5):413-417. PubMed ID: 37804284
[TBL] [Abstract][Full Text] [Related]
18. The Necrobiology of Mesenchymal Stromal Cells Affects Therapeutic Efficacy.
Weiss DJ; English K; Krasnodembskaya A; Isaza-Correa JM; Hawthorne IJ; Mahon BP
Front Immunol; 2019; 10():1228. PubMed ID: 31214185
[TBL] [Abstract][Full Text] [Related]
19. Chemical Engineering of Cell Therapy for Heart Diseases.
Li Z; Hu S; Cheng K
Acc Chem Res; 2019 Jun; 52(6):1687-1696. PubMed ID: 31125198
[TBL] [Abstract][Full Text] [Related]
20. hESC-Derived Epicardial Cells Promote Repair of Infarcted Hearts in Mouse and Swine.
Luo XL; Jiang Y; Li Q; Yu XJ; Ma T; Cao H; Ke MX; Zhang P; Tan JL; Gong YS; Wang L; Gao L; Yang HT
Adv Sci (Weinh); 2023 Sep; 10(27):e2300470. PubMed ID: 37505480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
